Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
Abstract Introduction Studies using different assays and technologies showed highly promising diagnostic value of plasma phosphorylated (P-)tau levels for Alzheimer’s disease (AD). We aimed to compare six P-tau Simoa assays, including three P-tau181 (Eli Lilly, ADx, Quanterix), one P-tau217 (Eli Lil...
Saved in:
Main Authors: | Sherif Bayoumy, Inge M. W. Verberk, Ben den Dulk, Zulaiga Hussainali, Marissa Zwan, Wiesje M. van der Flier, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Jeroen Vanbrabant, Erik Stoops, Eugeen Vanmechelen, Jeffrey L. Dage, Charlotte E. Teunissen |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/9a80f98ef3db432c84a8599a0bf54390 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
To target Tau pathologies, we must embrace and reconstruct their complexities
by: Galina Limorenko, et al.
Published: (2021) -
Simple, Single-Shot Phosphoproteomic Analysis of Heat-Stable Tau Identifies Age-Related Changes in pS235- and pS396-Tau Levels in Non-human Primates
by: Shannon N. Leslie, et al.
Published: (2021) -
Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein
by: Gaoping Lin, et al.
Published: (2021) -
A Computational Model of the Trans-Synaptic Spread of Pathogenic Tau in Early Alzheimer’s Disease
by: Bashir Sbaiti, et al.
Published: (2021) -
Differential Effects of Human P301L Tau Expression in Young versus Aged Mice
by: Holly C. Hunsberger, et al.
Published: (2021)